Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nymox Pharmaceutical (NYMXF)
OTHER OTC:NYMXF
Holding NYMXF?
Track your performance easily
NYMXF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $1.40
Previous Close$0.12
Volume1.33K
Average Volume (3M)12.89K
Market Cap
$11.22M
Enterprise Value$9.82M
Total Cash (Recent Filing)$1.40M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-380.72
Next Earnings
May 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding93,540,140
10 Day Avg. Volume11,600
30 Day Avg. Volume12,886
Standard Deviation0.63
R-Squared0.00065
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.07
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nymox Pharmaceutical News
PremiumPress Releases
Nymox Announces Filing of Annual Report
PremiumPress Releases
Nymox Annual Report
PremiumPress Releases
Nymox Required to Resubmit Application to DKMA
PremiumPress Releases
Nymox December 27 Message to Shareholders
Ownership Overview
53.04%
Insiders
0.05% Mutual Funds
0.04% Other Institutional Investors
46.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NYMXF FAQ
What was Nymox Pharmaceutical’s price range in the past 12 months?
Nymox Pharmaceutical lowest stock price was $0.01 and its highest was $1.40 in the past 12 months.
What is Nymox Pharmaceutical’s market cap?
Currently, no data Available
When is Nymox Pharmaceutical’s upcoming earnings report date?
Nymox Pharmaceutical’s upcoming earnings report date is May 15, 2024 which is 128 days ago.
How were Nymox Pharmaceutical’s earnings last quarter?
Currently, no data Available
Is Nymox Pharmaceutical overvalued?
According to Wall Street analysts Nymox Pharmaceutical’s price is currently Overvalued.
Does Nymox Pharmaceutical pay dividends?
Nymox Pharmaceutical does not currently pay dividends.
What is Nymox Pharmaceutical’s EPS estimate?
Nymox Pharmaceutical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nymox Pharmaceutical have?
Nymox Pharmaceutical has 93,540,140 shares outstanding.
What happened to Nymox Pharmaceutical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nymox Pharmaceutical?
Currently, no hedge funds are holding shares in NYMXF
---
Nymox Pharmaceutical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Nymox Pharmaceutical
Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
---
Technical Analysis
---